These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1818759)

  • 21. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
    Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
    Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the analgesic efficacy of pamidronate and synthetic human calcitonin in osteoporotic vertebral fractures: a double-blind controlled study.
    Laroche M; Cantogrel S; Jamard B; Constantin A; Zabraniecki L; Cantagrel A; Mazières B
    Clin Rheumatol; 2006 Sep; 25(5):683-6. PubMed ID: 16391891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multicenter comparative study of synthetic salmon calcitonin administered nasally in the treatment of established postmenopausal osteoporosis].
    Abellán Pérez M; Bayina García FJ; Calabozo M; Carpintero Benítez P; Figueroa Pedrosa M; Fernández Crisóstomo C; García López A; García Pérez S; Mesa Ramos M; Paulino Tevar J
    An Med Interna; 1995 Jan; 12(1):12-6. PubMed ID: 7718710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study.
    Armingeat T; Brondino R; Pham T; Legré V; Lafforgue P
    Osteoporos Int; 2006; 17(11):1659-65. PubMed ID: 16896508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Salmon calcitonin in osteoporosis. The effect of intranasal application on bone mineral content and fracture frequency in postmenopausal women with manifest osteoporotic changes].
    Overgaard K; Ravn P; Hansen MA; Christiansen C
    Ugeskr Laeger; 1993 Aug; 155(31):2387-91. PubMed ID: 8346588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture.
    Huusko TM; Karppi P; Kautiainen H; Suominen H; Avikainen V; Sulkava R
    Calcif Tissue Int; 2002 Dec; 71(6):478-84. PubMed ID: 12370798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal women.
    Rizzoli R; Sigaud A; Azria M; Herrmann FR
    Osteoporos Int; 2015 Jan; 26(1):383-93. PubMed ID: 25566730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.
    Overgaard K; Hansen MA; Jensen SB; Christiansen C
    BMJ; 1992 Sep; 305(6853):556-61. PubMed ID: 1393035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of calcitonin on chronic back pain and daily activities in postmenopausal women with osteoporosis.
    Papadokostakis G; Damilakis J; Mantzouranis E; Katonis P; Hadjipavlou A
    Eur Spine J; 2006 Mar; 15(3):356-62. PubMed ID: 16193299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analgesic effect of calcitonin in osteoporosis.
    Gennari C
    Bone; 2002 May; 30(5 Suppl):67S-70S. PubMed ID: 12008161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
    Tolino A; Romano L; Ronsini S; Riccio S; Montemagno U
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):358-60. PubMed ID: 8370634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
    McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
    J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.
    Chesnut CH; Majumdar S; Newitt DC; Shields A; Van Pelt J; Laschansky E; Azria M; Kriegman A; Olson M; Eriksen EF; Mindeholm L
    J Bone Miner Res; 2005 Sep; 20(9):1548-61. PubMed ID: 16059627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salmon calcitonin in the treatment of bone metastases.
    Serdengeçti S; Serdengeçti K; Derman U; Berkarda B
    Int J Clin Pharmacol Res; 1986; 6(2):151-5. PubMed ID: 3721646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
    Miller PD; Hattersley G; Riis BJ; Williams GC; Lau E; Russo LA; Alexandersen P; Zerbini CA; Hu MY; Harris AG; Fitzpatrick LA; Cosman F; Christiansen C;
    JAMA; 2016 Aug; 316(7):722-33. PubMed ID: 27533157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
    Meunier PJ; Sebert JL; Reginster JY; Briancon D; Appelboom T; Netter P; Loeb G; Rouillon A; Barry S; Evreux JC; Avouac B; Marchandise X
    Osteoporos Int; 1998; 8(1):4-12. PubMed ID: 9692071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of nandrolone decanoate and 1-alpha-hydroxy-calciferol on patients with vertebral osteoporotic collapse. A double-blind clinical trial.
    Lyritis GP; Androulakis C; Magiasis B; Charalambaki Z; Tsakalakos N
    Bone Miner; 1994 Dec; 27(3):209-17. PubMed ID: 7696887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group.
    Nevitt MC; Thompson DE; Black DM; Rubin SR; Ensrud K; Yates AJ; Cummings SR
    Arch Intern Med; 2000 Jan; 160(1):77-85. PubMed ID: 10632308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
    Tankó LB; Bagger YZ; Alexandersen P; Devogelaer JP; Reginster JY; Chick R; Olson M; Benmammar H; Mindeholm L; Azria M; Christiansen C
    J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.